1 / 4

Osteoarthritis Treatment Market Development by Companies and Comparative Analysis by 2027

Osteoarthritis also known as degenerative arthritis is the most commonly occurred chronic condition that affects joints, especially those in the knees, neck, and lower back.

Minal
Download Presentation

Osteoarthritis Treatment Market Development by Companies and Comparative Analysis by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Osteoarthritis Treatment Market Development by Companies and Comparative Osteoarthritis Treatment Market Development by Companies and Comparative Analysis by 2027 Analysis by 2027 Osteoarthritis also known as degenerative arthritis is the most commonly occurred chronic condition that affects joints, especially those in the knees, neck, and lower back. Osteoarthritis leads to severe joint pain and stiffness of the affected body part. These symptoms may occur in the initial stages following some physical exercise, however, persists long after the activity.  Several other symptoms of osteoarthritis include decreased range of motion, joint swelling as well as numbness of the legs and arms. This numbness is mostly found in the end joints of the fingers, neck, and lower back as well as base of the thumb, hips, and knees. The progression of osteoarthritis results in movement patterns and can ultimately result in joint effusion, usually in the knees. Osteoarthritis can be treated by several treatments, which include exercise for reducing joint pain, pain medications, and support groups. Pain medication includes drugs such as paracetamol, naproxen, and ibuprofen. Joint replacement is opted in cases of severe pain that results in interference with the regular activities. Osteoarthritis as one of the most prevalent chronic diseases across the globe Osteoarthritis as one of the most prevalent chronic diseases across the globe Centers for Disease Control and Prevention, 2016, reveals that there are over 100 types of arthritis and the most common form is osteoarthritis. Arthritis affected around 54.4 million adults in the U.S. during 2013- 2015. According to the Arthritis Foundation, 2014, over US$ 156 billion are dedicated annually in lost wages and medical expenses towards treatment of arthritis. Moreover, Barbour 2017 states that arthritis affects 1 in every 4 adults in U.S. The Arthritis Foundation also reveals that out of the 54.4 million arthritic patients in the U.S., around 30.8 million suffered from osteoarthritis, in 2015. These key stats provide direct growth opportunities to the key players involved in the global osteoarthritis treatment market. Request Sample Copy of Research Report @ Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/915 https://www.coherentmarketinsights.com/insight/request-sample/915 The global osteoarthritis treatment market is segmented on the basis of medications, therapies, end-user, The global osteoarthritis treatment market is segmented on the basis of medications, therapies, end-user, and geography. and geography. On the basis of medications, the global osteoarthritis treatment market is segmented into: On the basis of medications, the global osteoarthritis treatment market is segmented into: Acetaminophen • Non- Steroidal Anti- Inflammatory •

  2. Based on the therapies, the global osteoarthritis treatment market is segmented into: Based on the therapies, the global osteoarthritis treatment market is segmented into: Non- Pharmacological Therapy • Pharmacological Therapy • Surgical Treatment • On the basis of end-user, the global osteoarthritis treatment market is segmented into: On the basis of end-user, the global osteoarthritis treatment market is segmented into: Hospitals • Clinics • • Household Cost-effective and innovative medications responsible to drive the global osteoarthritis treatment market Cost-effective and innovative medications responsible to drive the global osteoarthritis treatment market The emergence of new and cost effective medications for the treatment of osteoarthritis is the major growth driver of the global osteoarthritis treatment market. The Tanezumab, a drug jointly developed by Pfizer and Eli Lily, 2017, used for the chronic lower back pain relief in osteoarthritis, is awaiting FDA approval, which is expected to help millions of people. Obesity, increasing number of orthopedic injuries, crystal deposition, old age, joint injury, increasing number of pipeline drugs, and rising awareness among people are few other factors responsible for driving growth of the global osteoarthritis treatment market. However, less adoption of osteoarthritis treatment and side effects associated with of these treatments are expected to hinder the growth of the global osteoarthritis treatment market. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Osteoarthritis Treatment Market Research Objective and Assumption • Osteoarthritis Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Osteoarthritis Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Osteoarthritis Treatment Market, By Regions • Osteoarthritis Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Osteoarthritis Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Osteoarthritis Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market

  3. Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Osteoarthritis Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Osteoarthritis Treatment Market – Regional Insights Osteoarthritis Treatment Market – Regional Insights On the basis of region, the global Osteoarthritis Treatment Market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global Osteoarthritis Treatment Market, owing to well-established healthcare facilities, extensive research and development activities, high per capita healthcare expenditure, and promising medical reimbursement policies in the region. Buy Now This Research Report @ Buy Now This Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/915 https://www.coherentmarketinsights.com/insight/buy-now/915 The key players are focusing on R&D to establish their presence in the global osteoarthritis treatment The key players are focusing on R&D to establish their presence in the global osteoarthritis treatment market market The key players operating the global osteoarthritis market are Johnson & Johnson Ltd., Abbott Laboratories, Pfizer, Inc., Novartis AG, Eli Lily and Co., Abiogen Pharma, Ampio Pharmaceuticals, Halyard Health, and BioDelivery Sciences International, Inc. The companies are involved in introducing new and innovative products for the osteoarthritis treatment to increase sales in the global market. For instance, the Halyard Health introduced the first cooled radiofrequency (RF), minimally invasive needles, and water cooled electrodes that are specifically used to alleviate chronic knee pain in osteoarthritis. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200

  4. Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related